GenTegra
GenTegra LLC is dedicated to improving the quality of biological research and medical care by protecting sample integrity through proprietary Active Chemical Protection™ technology. They develop solutions for maintaining the pristine quality of biological specimens, including nucleic acids, proteins, and other biomolecules, enabling reliable results in clinical, research, and forensic applications. Their products include sample stabilization for RNA, DNA, and other biomolecules, suitable for various applications such as genomics, transcriptomics, forensic analysis, and remote sample collection. The company's mission emphasizes innovation, collaboration, and providing cost-effective solutions to preserve biological samples without the need for cold chain logistics.
Industries
Nr. of Employees
small (1-50)
GenTegra
Pleasanton, California, United States, North America
Patents
Products
RNA stabilization tube (purified-RNA protection)
Tube and plate formats designed to receive purified RNA and immediately protect it from RNases and environmental degradation for short-term ambient storage and shipping for sequencing.
Paper-based RNA/DNA collection cards
Filter-paper sample cards treated with stabilizing chemistries for dried blood spots and other sample types to permit ambient transport and storage, including cards with enhanced antimicrobial properties for forensic storage.
Viral stabilization transport formulations
Dry and low-volume transport media formulated to stabilize viruses and viral RNA in saliva and swab samples at ambient temperature for extended periods, while inactivating virus and avoiding guanidine thiocyanate to maintain compatibility with bleach-based automated cleaners.
Dry-bulk RNA stabilizer for automated processing
Dry bulk chemical stabilizer intended for integration into automated workflows and high-throughput labs, providing a shelf-stable format that is reconstituted prior to use and supports multiple rehydration cycles.
Pre-treated microsampling tips for RNA preservation
Stabilization solution applied to VAMS microsampling tips to enable remote finger-stick blood collection with short-term ambient storage prior to laboratory RNA extraction.
RNA stabilization tube (purified-RNA protection)
Tube and plate formats designed to receive purified RNA and immediately protect it from RNases and environmental degradation for short-term ambient storage and shipping for sequencing.
Paper-based RNA/DNA collection cards
Filter-paper sample cards treated with stabilizing chemistries for dried blood spots and other sample types to permit ambient transport and storage, including cards with enhanced antimicrobial properties for forensic storage.
Viral stabilization transport formulations
Dry and low-volume transport media formulated to stabilize viruses and viral RNA in saliva and swab samples at ambient temperature for extended periods, while inactivating virus and avoiding guanidine thiocyanate to maintain compatibility with bleach-based automated cleaners.
Dry-bulk RNA stabilizer for automated processing
Dry bulk chemical stabilizer intended for integration into automated workflows and high-throughput labs, providing a shelf-stable format that is reconstituted prior to use and supports multiple rehydration cycles.
Pre-treated microsampling tips for RNA preservation
Stabilization solution applied to VAMS microsampling tips to enable remote finger-stick blood collection with short-term ambient storage prior to laboratory RNA extraction.
Services
Collaboration and co-development with device manufacturers and research organizations to adapt chemical stabilization formulations to specific collection devices (e.g., microsampling tips, blood cartridges) and workflows.
Provision of small trial/sample kits (e.g., 3-tube evaluation kits) and packaged product samples to laboratories for performance evaluation prior to purchase.
Agreements with distribution partners to supply high-density sample formats and treated paper products to international markets and biobanks.
Collaboration and co-development with device manufacturers and research organizations to adapt chemical stabilization formulations to specific collection devices (e.g., microsampling tips, blood cartridges) and workflows.
Provision of small trial/sample kits (e.g., 3-tube evaluation kits) and packaged product samples to laboratories for performance evaluation prior to purchase.
Agreements with distribution partners to supply high-density sample formats and treated paper products to international markets and biobanks.
Expertise Areas
- Ambient-temperature nucleic acid stabilization
- Biobanking and dried sample storage
- Forensic DNA sample preservation
- RNA sample protection for sequencing workflows
Key Technologies
- Chemical nuclease-inactivating matrices
- Filter paper-based collection cards
- Dried blood spot microplate (384-format) storage
- Volumetric absorptive microsampling (VAMS) compatibility
News & Updates
GenTegra announced the launch of RNAssure™, a product designed to protect RNA immediately after purification, allowing for room temperature stability for up to 4 days and safe shipping for RNAseq samples.
GenTegra announced the launch of RNAdvantage™, a product for stabilizing and protecting RNA in fresh tissue samples, in addition to existing products for liquid RNA and long-term storage.
GenTegra and Thorne HealthTech announced a collaboration to develop a next-generation whole blood DNA collection and stabilization kit using GenTegra’s technology and Thorne’s collection device.
GenTegra received a $2.8 million SBIR grant from NIAID to develop filter paper technologies for the collection and stabilization of RNA in blood and plasma at ambient temperatures.
GenTegra was awarded a $1.8 million SBIR grant from NIH to develop filter paper technology for collection and stabilization of RNA virus in blood and plasma at ambient temperatures.
GenTegra received a $2.8 million SBIR grant from NIAID for developing RNA collection and stabilization products for field use, including for viruses like Zika.
GenTegra announced the launch of RNAssure™, a product designed to protect RNA immediately after purification, allowing for room temperature stability for up to 4 days and safe shipping for RNAseq samples.
GenTegra announced the launch of RNAdvantage™, a product for stabilizing and protecting RNA in fresh tissue samples, in addition to existing products for liquid RNA and long-term storage.
GenTegra and Thorne HealthTech announced a collaboration to develop a next-generation whole blood DNA collection and stabilization kit using GenTegra’s technology and Thorne’s collection device.
GenTegra received a $2.8 million SBIR grant from NIAID to develop filter paper technologies for the collection and stabilization of RNA in blood and plasma at ambient temperatures.
GenTegra was awarded a $1.8 million SBIR grant from NIH to develop filter paper technology for collection and stabilization of RNA virus in blood and plasma at ambient temperatures.
GenTegra received a $2.8 million SBIR grant from NIAID for developing RNA collection and stabilization products for field use, including for viruses like Zika.